Iconiq Capital’s Cardinal Health CAH Stock Holding History

Iconiq Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,593	Closed	-$268K	–	147
2025 Q2	$268K	Buy	1,593 +12	+0.8%	+$1.78K	﹤0.01%	313
2025 Q1	$218K	Buy	+1,581	New	+$202K	﹤0.01%	351

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Iconiq Capital's CAH Position: Q3 2025 in Review

Iconiq Capital sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 1,593 shares — an estimated $268K sold.

Iconiq Capital first reported a position in CAH in Q1 2025 and held it in 2 quarters. The position peaked at $268K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

Iconiq Capital reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
Iconiq Capital sold 1,593 Cardinal Health shares in Q3 2025, an estimated $268K.
Iconiq Capital first reported a position in Cardinal Health in Q1 2025 and held it in 2 quarters.
Iconiq Capital's Cardinal Health position peaked at $268K in Q2 2025.
1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Iconiq Capital's 13F filing for Q3 2025, filed 14 Nov 2025.